Adient: Onshoring Momentum and Conquest Wins Fuel a Mid‑Term Long
Adient's recent commercial wins tied to onshoring and OEM conquest programs have bulked up a backlog that should support revenue visibility into the next several quarters. At ~ $17.75, the stock is priced for a slow recovery; the combination of $295M free cash flow, a sub‑$1.4B market cap and a low P/B multiple offers a compelling risk/reward for a…